FDA Clears First Vaginal Ring for 1 Year of Birth Control FDA Clears First Vaginal Ring for 1 Year of Birth Control
Annovera (segesterone acetate and ethinyl estradiol vaginal system) is the first vaginal ring contraceptive approved that provides a full year of protection against unintended pregnancy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news
FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ -- The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera ™ (segesterone acetate and ethinyl estradiol vaginal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news
FDA approves new vaginal ring for one year of birth control
FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news
A moderate estradiol level enhances neutrophil number and activity in muscle after traumatic injury but strength recovery is accelerated - Le G, Novotny SA, Mader TL, Greising SM, Chan SSK, Kyba M, Lowe DA, Warren GL.
Estrogen has been shown to protect against skeletal muscle injury and a reduced inflammatory response has been suggested as a possible protective mechanism. There are, however, dissenting reports. Our objective was to conduct an unbiased, comprehensive stu... (Source: SafetyLit)
Source: SafetyLit - July 27, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Esclim (Estradiol Transdermal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2018 Category: Drugs & Pharmacology Source Type: news
EstroGel (Estradiol Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 20, 2018 Category: Drugs & Pharmacology Source Type: news
Estradiol to androstenedione ratios moderate the relationship between neurological injury severity and mortality risk after severe TBI - Ranganathan P, Kumar RG, Oh BM, Rakholia MV, Berga S, Wagner AK.
Early declines in gonadotropin production, despite elevated serum estradiol, among patients with severe traumatic brain injury (TBI) suggests amplified aromatization occurs post-injury. Our previous work identifies estradiol (E2) as a potent mortality mark... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Femcon Fe (Norethindrone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2018 Category: Drugs & Pharmacology Source Type: news
Imvexxy (Estradiol Vaginal Inserts) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2018 Category: Drugs & Pharmacology Source Type: news
Norethindrone and Ethinyl Estradiol Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 20, 2018 Category: Drugs & Pharmacology Source Type: news
New study suggests ovarian hormone may make drug withdrawal symptoms worse for women
(Dickinson College) Researchers found that a form of the estrogen hormone can contribute to drug relapse in females by worsening withdrawal symptoms. The study looked at the interaction of the female sex hormone estradiol and methamphetamine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 18, 2018 Category: International Medicine & Public Health Source Type: news
Testosterone May Be Key to CVD Risk in Women Testosterone May Be Key to CVD Risk in Women
A new analysis shows that higher testosterone levels and a higher ratio of testosterone to estradiol in postmenopausal women are associated with higher risk for cardiovascular disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Does stabilizing female hormones help lower suicide risk?
(University of Illinois at Chicago) A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news
Oral Semaglutide Success; Lowest-Dose Vaginal Estradiol OK'd
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 1, 2018 Category: Urology & Nephrology Source Type: news
Postmenopausal Sex Hormone Levels Associated With Later CVD
FRIDAY, June 1, 2018 -- In postmenopausal women, higher testosterone/estradiol ratios are associated with increased risks for incident cardiovascular disease (CVD), coronary heart disease (CHD), and heart failure events, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2018 Category: Pharmaceuticals Source Type: news
